AL-37807 Ophthalmic Suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-37807 Ophthalmic Suspension, covering 2012-12-05 to 2012-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Adjunctive Study of AL-37807 Ophthalmic Suspension [Phase 2]